USPTO serial 78175950
MINDGENIX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BLANDU, FLORENTINA
- Law office
- DIVISIONAL UNIT
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MINDGENIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
J. Scott Evans
J SCOTT EVANS ADAMS SCHWARTZ & EVANS PA301 S TRYON ST2180 TWO WACHOVIA CTRCHARLOTTE, NC 28282Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific, medical and mechanical research; biochemical analysis; biochemical research; drug design for others | ACTIVE | — |
| 044 | Medical services, namely, diagnosis of predisposition to neurodegeneration and Alzheimer's disease, disease management, prophylaxis and treatment of medical disorders, prophylaxis and treatment of Alzheimer's disease patients and neurodegenerative patients and vaccination of neurodegeneration disease and Alzheimer's disease patients; healthcare | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mindset Biopharmaceuticals (USA) Inc.
- Other trademarks owned by Mindset Biopharmaceuticals (USA) Inc.
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MINDGENIX
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 31, 2005 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 28, 2005 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 23, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 30, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 10, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 4, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 15, 2003 | CFIT | CASE FILE IN TICRS | — |
| Sep 15, 2003 | 44DD | SEC. 44(D) CLAIM DELETED | — |
| Sep 15, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 15, 2003 | PAPER RECEIVED | — | |
| Mar 25, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 6, 2002 | PAPER RECEIVED | — |